Advertisement
Skip to Content

Revenio Group Oyj REVXF Stock Quote

| Rating as of

GREY: REVXF

Last close prices updated as of Jun 17, 2022, 9:52 AM EST | USD
  • Last Close 44
  • Sector Healthcare
  • Industry Medical Devices
  • Investment Style Small Growth
  • Day Range 44.00  –  44.00
  • Year Range 44.00  –  44.88
  • Market Cap 1.1689 Bil
  • Volume / Avg 793.0 /  793.0
  • Price / Sales 13.36
  • Price / Book 14.76
  • Forward Div Yield 0.84%
  • Trailing Div Yield 0.77%

Morningstar‘s Stock Analysis REVXF

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics REVXF

Company Profile REVXF

Business Description

Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.

Contact
Ayritie 22
Vantaa, 01510, FIN
Industry Medical Devices
Employees 191

FAQs for Revenio Group Oyj Stock

Yes. REVXF has a forward dividend yield of 0.84%. See REVXF’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

REVXF’s market cap is 1.17 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

REVXF’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

REVXF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare REVXF’s historical performance against its industry peers and the overall market.